Martingale Asset Management »

Neurocrine Biosciences shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $92k 12k 7.54

More positions owned by Martingale Asset Management

Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
Apple (AAPL)
Johnson & Johnson (JNJ)
UnitedHealth (UNH)
Berkshire Hathaway (BRK.B)
Merck & Co (MRK)
Costco Wholesale Corporation (COST)
Procter & Gamble Company (PG)
Visa (V)
Adobe Systems Incorporated (ADBE)
Eli Lilly & Co. (LLY)
Cisco Systems (CSCO)
Intuit (INTU)

View all positions for Martingale Asset Management

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences